Sun-Young Kong
Sun-Young Kong
Verified email at
Cited by
Cited by
Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients
JH Shim, JW Park, JH Kim, M An, SY Kong, BH Nam, JI Choi, HB Kim, ...
Cancer science 99 (10), 2037-2044, 2008
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
YT Tai, BY Chang, SY Kong, M Fulciniti, G Yang, Y Calle, Y Hu, J Lin, ...
Blood, The Journal of the American Society of Hematology 120 (9), 1877-1887, 2012
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
J Jakubikova, S Adamia, M Kost-Alimova, S Klippel, D Cervi, JF Daley, ...
Blood, The Journal of the American Society of Hematology 117 (17), 4409-4419, 2011
Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
SH Kang, KW Kang, KH Kim, B Kwon, SK Kim, HY Lee, SY Kong, ES Lee, ...
BMC cancer 8 (1), 286, 2008
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti‐myeloma activity in vitro and in vivo
K Kim, SY Kong, M Fulciniti, X Li, W Song, S Nahar, P Burger, ...
British journal of haematology 149 (4), 537-549, 2010
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
M Cea, A Cagnetta, M Fulciniti, YT Tai, T Hideshima, D Chauhan, ...
Blood, The Journal of the American Society of Hematology 120 (17), 3519-3529, 2012
Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients
SY Kong, JW Park, JA Lee, JE Park, KW Park, EK Hong, CM Kim
Hepatology 46 (2), 446-455, 2007
Breast cancer diagnosis using a microfluidic multiplexed immunohistochemistry platform
MS Kim, T Kim, SY Kong, S Kwon, CY Bae, J Choi, CH Kim, ES Lee, ...
PloS one 5 (5), e10441, 2010
Dual inhibition of canonical and noncanonical NF-ęB pathways demonstrates significant antitumor activities in multiple myeloma
C Fabre, N Mimura, K Bobb, SY Kong, G Gorgun, D Cirstea, Y Hu, ...
Clinical Cancer Research 18 (17), 4669-4681, 2012
Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer
SY Kong, BH Nam, KS Lee, Y Kwon, ES Lee, MW Seong, DH Lee, J Ro
Clinical chemistry 52 (8), 1510-1515, 2006
Prognostic implications of tumor-infiltrating lymphocytes in association with programmed death ligand 1 expression in early-stage breast cancer
IH Park, SY Kong, JY Ro, Y Kwon, JH Kang, HJ Mo, SY Jung, S Lee, ...
Clinical breast cancer 16 (1), 51-58, 2016
Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma
H Lee, SY Kong, JY Sohn, H Shim, HS Youn, S Lee, HJ Kim, HS Eom
BioMed research international 2014, 2014
Serum HE4 level is an independent prognostic factor in epithelial ovarian cancer
SY Kong, MH Han, HJ Yoo, JH Hwang, MC Lim, SS Seo, CW Yoo, JH Kim, ...
Annals of surgical oncology 19 (5), 1707-1712, 2012
CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
SR Park, SY Kong, BH Nam, IJ Choi, CG Kim, JY Lee, SJ Cho, YW Kim, ...
British journal of cancer 104 (7), 1126-1134, 2011
Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy
JY Kim, S Park, BH Nam, JW Roh, CH Lee, YH Kim, HJ Shin, SK Lee, ...
Journal of clinical oncology 27 (30), 5088-5093, 2009
BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients
MC Lim, S Kang, SS Seo, SY Kong, BY Lee, SK Lee, SY Park
Journal of cancer research and clinical oncology 135 (11), 1593-1599, 2009
Serum HER-2 concentration in patients with primary breast cancer
SY Kong, JH Kang, Y Kwon, HS Kang, KW Chung, SH Kang, DH Lee, ...
Journal of clinical pathology 59 (4), 373-736, 2006
Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma
HJ Cho, HS Eom, HJ Kim, IS Kim, GW Lee, SY Kong
Cancer genetics and cytogenetics 198 (1), 40-46, 2010
Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1. 24 antibody against multiple myeloma via augmented effector function
YT Tai, HM Horton, SY Kong, E Pong, H Chen, S Cemerski, MJ Bernett, ...
Blood, The Journal of the American Society of Hematology 119 (9), 2074-2082, 2012
Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling
BC Yoo, SY Kong, SG Jang, KH Kim, SA Ahn, WS Park, S Park, T Yun, ...
BMC cancer 10 (1), 55, 2010
The system can't perform the operation now. Try again later.
Articles 1–20